What dilution or supply shock could arise from the underwriters' 30âday option to purchase up to 2,250,000 additional shares?
The underwritersâ 30âday âgreenshoeâ option creates a modest but measurable secondaryâsupply shock. If exercised in full, 2.25âŻmillion extra ClassâŻA shares will be poured back into the market at the same $12.75 price as the primary 15âŻmillionâshare sale. For a company whose float is roughly 30âŻmillion shares (typical for a NASDAQâlisted growth firm), this represents a 7â8âŻ% increase in available stock over the next monthâplus. The incremental supply can trigger shortâterm downward pressure on the price, especially if demand from institutional investors does not keep pace with the added liquidity.
From a fundamentals standpoint, the capital raise is not for dLocal itselfâthe proceeds remain with the selling shareholderâso there is no change to the firmâs balance sheet or growth trajectory. Nevertheless, the market will treat the extra shares as a dilution of existing ownership stakes: each holderâs proportionate slice of future earnings and cashâflow will be modestly reduced, which can modestly compress valuation multiples if the market anticipably spreads the offering across a larger share base.
Trading implication: Anticipate a briefâterm dip or heightened volatility around the offering close (SeptâŻ5) and during the greenâshoe window (nextâŻ30âŻdays). Positionally, a shortâterm sellâorâreduce stance on DLO near the $12.75 level can capture the supplyâshock bounceâback, while a tighter stop just above the offering price limits downside if execution is limited. If the option is not exercised, the price may rebound more quickly; monitoring the underwritersâ demand signalsâe.g., largeâblock purchasesâwill be key to gauging how much of the 2.25âŻMâshare allotment will actually hit the market.